Medplus Health Q1 FY27 Results (NSE: MEDPLUS)
Signal: Steady quarter
The read
Revenue growth accelerated to +21.8% YoY — the fastest in six quarters — but the quality of earnings deteriorated: retail segment profit fell ~30% YoY as gross margin compressed, and consolidated PAT slumped 21.6% YoY as other income halved and the effective tax rate rose. Standalone performance was stronger (PAT +29% YoY), suggesting profits are being retained at subsidiaries or some subsidiaries are loss-making. The board approved two large capex plans — ₹400 Mn food park and ₹1,150 Mn wellness facility — signaling an expansion into higher-margin adjacencies, but near-term profitability is under pressure from margin compression and lower other income.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹187.96 Cr | 21.8% | 0.8% |
| EBIT | ₹75.15 Cr | -34.0% | |
| Net profit | ₹3.32 Cr | -21.6% | |
| EPS | ₹2.76 | -22.0% | |
| EBIT margin | 6.5% |
P&L walk
Revenue grew 21.8% YoY (ahead of prior quarters' trends), but gross margin contracted ~112bps as cost of goods sold rose faster; EBITDA margin compressed 9bps YoY despite employee cost leverage; sharp drop in other income (-49.1% YoY) and higher effective tax rate drove PAT down 21.6% YoY.
Segments
Retail segment revenue grew 21.8% YoY to ₹18,423.92 Mn, but segment profit dropped 29.8% YoY to ₹315.63 Mn — indicating margin pressure at the store level; diagnostic services segment profit surged to ₹23.24 Mn vs ₹0.77 Mn a year ago, a strong turnaround on higher revenue of ₹370.76 Mn (+22.4% YoY).
Key positives
- Revenue growth accelerated to +21.8% YoY, the highest in the trailing 5 quarters, driven by retail segment (+21.8%) and diagnostic services (+22.4%).
- Diagnostic services segment profit jumped from ₹0.77 Mn to ₹23.24 Mn YoY — a strong inflection from near-breakeven to meaningful contribution.
- Employee cost grew only 20.7% YoY vs revenue +21.8%, providing 119bps of leverage as employee cost-to-revenue dropped from 14.1% to 12.9%.
- Standalone PAT grew 29.0% YoY to ₹174.51 Mn, showing the parent company's cost discipline and lower finance costs (+3.2% YoY only).
Key concerns
- Consolidated PAT fell 21.6% YoY to ₹331.67 Mn — first YoY decline in PAT in at least 6 quarters — driven by other income dropping 49.1% YoY, higher effective tax rate (20.8% vs 19.8%), and lower retail segment profit.
- Retail segment profit dropped 29.8% YoY to ₹315.63 Mn despite 21.8% revenue growth — implying severe margin compression at the store level (cost of goods sold as % of revenue rose ~112bps YoY).
- Other income collapsed to ₹198.26 Mn from ₹150.19 Mn YoY (a 49.1% decline), amplifying the PAT drop.
- Q1FY27 EBITDA margin of ~6.5% is the lowest in the last 5 quarters, reversing the margin expansion trend seen from Q2FY25 through Q4FY26.
Research and educational content only. Not investment advice.